Lloyd Price

SEPTEMBER 2, 2023

Growth of the life sciences sector: The life sciences sector is expected to continue to grow in 2023, driven by the development of new drugs and therapies, as well as the increasing demand for personalized medicine. The overall outlook for the European HealthTech M&A market in 2023 is positive.

Life Science 67

Life Science Digital Health EHR BioTech 67

Healthcare IT Today

JANUARY 8, 2024

Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. The trend is driven by a growing focus on health equity and proactive, personalized care. Dave Latshaw, CEO at BioPhy 1.

Health IT 111

Health IT Drug Development Pharmaceuticals BioTech 111

Healthcare IT Today

OCTOBER 11, 2023

which will partner with 20+ health system partners to guide their transition to value-based care and potentially acquire a health system “where we can demonstrate the blueprint of this transformation for the rest of the industry.” Elation Health released an integrated EHR and billing suite for primary care.

Life Science 73

Life Science EHR BioTech RCM 73

Healthcare IT Today

NOVEMBER 20, 2022

Firefly Health and Sprinter Health are integrating Firefly’s in-home clinical services with Sprinter’s virtual primary care. Primary care EHR Elation Health has integrated with Ribbon Health , a provider data management platform. The Biotech Breakthrough Awards Program announced its 2022 award winners.

eCare 52

eCare BioTech Primary Care Life Science 52